webleads-tracker

Pharma Compliance Info FDA Reverses Long-Standing Policy of Not Publicly Posting Individuals' Comments Digital

FDA Reverses Long-Standing Policy of Not Publicly Posting Individuals’ Comments

As part of its shift to increase transparency, the US Food and Drug Administration (FDA) said on Thursday that beginning 15 October it will publicly post individuals’ comments on the regulations docket.
The new policy could potentially have an impact on lobbyists or other special interest groups submitting comments as individuals.
“In 1995, FDA explained that it routinely reviewed all comments for obvious confidential information before placing the comments in the docket (60 FR 66982), but this practice is no longer feasible given factors such as the volume of comments FDA receives and the adoption of a government-wide electronic portal system for submitting and posting comments,” FDA said.
To read the article by Zachary Brennan

Check Also

Pharma Compliance Info Le numérique au cœur des nouveaux usages en santé Digital

Le numérique au cœur des nouveaux usages en santé

La 11ème vague du baromètre 360° sur la santé était axée  la thématique des« nouveaux usages en santé » …

X